The fact that Israel has been able to vaccinate a huge chunk of its population is worthy of praise. What’s equally as intriguing is just how has Israel managed to get so many vaccinations at a time when the world was rushing to buy them. Simon Griver, the managing editor of Globes on Line, Israel’s financial newspaper, who has been researching the story, told reporter Arieh O’Sullivan that it could be that Israel paid more for the vaccines, and that Pfizer-BioNTech may have seen a successful inoculation plan in Israel as a marvelous advertisement.